322sek
-3,6 %
Date:2025-05-15Time:18:00:00Latest report:Q1-2025List:First NorthTicker:ENZY
Market Cap:782 msekEnterprise Value:716 msekNet Sales:48,4 msekEarnings:-52,3 msekEmployees:0ISIN:SE0003943620
Ratios
10-year key figure history for Enzymatica turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Enzymatica with index and moving average MA50 and MA200.
Stockprice:3,22
MA50:3,61
MA200:2,29
Price/MA200:40,8 %
RSI (14):50,9
Price/MA50:-10,7 %
Description
Enzymatica is a life science company that develops and sells medical devices for infection-related diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray which can prevent colds as well as shorten the illness period. The product has been launched on several markets and the strategy is to expand to more markets via partners. The company is headquartered in Lund.